Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
13.30
-0.04 (-0.30%)
Jul 20, 2026, 10:31 AM EDT - Market open
Kazia Therapeutics Market Cap
Kazia Therapeutics has a market cap or net worth of $151.98 million as of July 20, 2026. Its market cap has increased by 1,239.58% in one year.
Market Cap
151.98M
Enterprise Value
106.17M
1-Year Change
1,239.58%
Ranking
Category
Stock Price
$13.30
ChartMarket Cap Chart
Since September 1, 1999, Kazia Therapeutics's market cap has increased from $141.44M to $151.98M, an increase of 7.45%. That is a compound annual growth rate of 0.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 151.98M | 94.58% |
| Dec 31, 2025 | 78.10M | 913.26% |
| Dec 31, 2024 | 7.71M | -33.47% |
| Dec 29, 2023 | 11.59M | 15.31% |
| Dec 30, 2022 | 10.05M | -90.96% |
| Dec 31, 2021 | 111.18M | 11.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caribou Biosciences | 163.65M |
| Acumen Pharmaceuticals | 162.51M |
| LENZ Therapeutics | 162.42M |
| Innate Pharma | 161.91M |
| Milestone Pharmaceuticals | 161.22M |
| PepGen | 155.63M |
| Connect Biopharma Holdings | 149.85M |
| Pyxis Oncology | 149.52M |